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MTT assayAbstract As part of a continuing search for the synthesis of new antimicrobial agents some macro-
cyclic tetradentate nitrogen donor (N4) ligand based transition metal complexes of the type
[M(C12H20O8N4)Cl2] where M= Cu(II), Ni(II) and Co(II) were of our interest. All the compounds
were synthesized and evaluated in vitro for their anticandidal property by performing minimum
inhibitory concentration (MIC) along with ergosterol composition assay against Candida albicans
ATCC 10261, Candida glabrata ATCC 90030, and Candida tropicalis ATCC 750, respectively.
Results obtained indicate that growth and ergosterol content decreased signiﬁcantly in the presence
of the test compounds. All the synthesized compounds under investigation were also tested for tox-
icity byMTT assay on H9c2 cardiac myoblasts and the results showed that these compounds and the
ligand offered remarkable viability in the range of 87–94% at a concentration of 25 lM. Ni(II) com-
plex (KNi) was found to be the most active and least cytotoxic among all the compounds screened.
ª 2011 Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Schiff base complexes are considered to be among the most
important stereochemical models in main group and transition
metal coordination chemistry due to their preparative accessi-
bility and structural variety (Alexander, 1995). Study of the
interaction between drugs and transition metals is an impor-
tant and active research area in bioinorganic chemistry
(Albert, 1979; Hughes, 1981; Tao et al., 2003; Chakrabarti
S744 R.A. Sheikh et al.et al., 2000). It is well known that the action of many drugs is
dependent on the coordination with metal ions (Albert, 1979)
or/and the inhibition (Hughes, 1981) on the formation of
metalloenzymes. Therefore, metal ions might play a vital role
during the biological process of drug utilization in the body.
A large number of Schiff bases and their complexes have been
studied for their interesting and important properties, e.g. their
ability to reversibly bind oxygen (Jones et al., 1979), catalytic
activity in the hydrogenation of oleﬁns (Olie and Olive,
1984) and transfer of an amino group (Dugas and Penney,
1981), photochromic properties (Margerum, 1971), and com-
plexing ability toward some toxic metals (Sawodny and Rie-
derer, 1977). The high afﬁnity for the chelation of the Schiff
bases toward the transition metal ions is utilized in preparing
their solid complexes. Schiff bases are potential anticancer
drugs and, when administered as their metal complexes, the
anticancer activity of these complexes is enhanced in
comparison to the free ligand (Shahabadi et al., 2010). Some
biologically active Schiff base ligands, hydrazine-pyrrole-2-
carboxaldehyde, hydrazine-furan-2-carboxaldehyde and
hydrazine-thiophene-2-carboxaldehyde and their phenyl deriv-
atives and their Co(II), Cu(II) and Ni(II) mixed complexes
have been synthesized and characterized (Chohan, 2008).
Complexes of Cu(II), Ni(II), Zn(II), Pd(II) and UO2(II) with
a tridentate ONS donor Schiff base; 3-(o-mercaptophenyl-imi-
nomethyl) salicylic acid, were synthesized and characterized by
Nag et al. (2005). Presently the primary and opportunistic fun-
gal infections continue to increase rapidly because of the in-
creased number of immunocompromised patients. As known,
not only biochemical similarity of the human cell and fungi
forms a handicap for selective activity, but also the easily
gained resistance is the main problem encountered in develop-
ing safe and efﬁcient antifungals. Candidiasis, a fungal disease
caused by a diploid opportunistic fungal pathogen Candida
proves to be life threatening mycoses fatal for immuno com-
promised patients, e.g. AIDS and transplantation surgery
(Lott et al., 2005). Risk factors that increase incidence of Can-
dida infection include compromised immunity, hormonal
imbalances, prolonged use of broad spectrum antibiotics and
oral contraceptives, pregnancy, metabolic and nutritional dis-
orders (Odds, 1985; D’Souza and Heitman, 2001). Number of
antifungal agents are available for the treatment of Candidal
infections (Gupta and Thomas, 2003; Carrillo-Munoz et al.,
2006) majority of them being polyenes such as Amphotericin
B and Nystatin or the azoles, such as Itraconazoles and Fluco-
nazole. Currently, use of standard antifungal therapies is scare
due to the high toxicity, low efﬁcacy rates, and drug resistance.
Recent studies have indicated C. albicans resistance to azoles
or heptotoxicity and nephrotoxicity linked to polyene use, par-
ticularly amphotericin B (Chami et al., 2004). Therefore, our
studies were conducted to synthesize some macrocyclic tetra-
dentate ligand based transition metal complexes and screen
them for their anticandidal activity.
2. Materials and methods
2.1. Chemistry
Solvents and organic reagents were purchased from Sigma
Aldrich, Merck (Germany) and Loba Chemie (India), and
were used without further puriﬁcation. Melting points (mp)were performed using a Mel-temp instrument, and the results
were uncorrected. Elemental analyses were performed on
HeraeusVario EL III analyzer at the Central Drug Research
Institute, Lucknow, India. The results were within ±0.4% of
the theoretical values. Electronic spectra were recorded on a
Shimadzu UV 1601 PC UV–Visible spectrophotometer. IR
spectra were recorded on Perkin–Elmer model 1600 FT-IR
RX1 spectrophotometer as KBr discs. Far IR spectra were
recorded as CsI pellets in the region 650–100 cm1 using a
JASCO FT-IR spectrophotometer. 1H NMR and 13C NMR
spectra were recorded on Bruker AVANCE 400 spectrometer
using DMSO-d6 as solvent with TMS as the internal standard.
Positive and negative Thermal analysis (TG/DTA) data were
studied under nitrogen atmosphere using a SII Ex Star 6000
TG/DTA 6300 instrument. Magnetic susceptibility measure-
ments were carried out from a microanalysis laboratory by
Gouy method at room temperature. Splitting patterns are des-
ignated as follows: s, singlet; d, doublet; dd, double doublet; t,
triplet; m, multiplet. Chemical shift values are given in ppm.
ESI MS was recorded on a MICROMASS QUATTRO II tri-
ple quadrupole mass spectrometer. Reactions were monitored
using thin-layer chromatography (TLC) using commercially
available precoated plates (Merck Kieselgel 60 F254 silica).
Visualization was achieved with UV light at 254 nm or I2
vapor staining.
2.1.1. Synthesis of ligand: 6, 7, 14, 15-tetrahydroxy-1, 4, 9, 12-
tetraazacyclohexadecane-5, 8, 13, 16-tetrone (1)
The hot ethanolic solution (25 ml), of tartaric acid (8.30 g,
0.05 mol) and a hot ethanolic solution (25 ml) of ethylenedia-
mine (3.00 g, 0.05 mol) were mixed slowly with constant stir-
ring. This mixture was reﬂuxed at 60–70 C for 7 h in
presence of few drops of concentrated hydrochloric acid. On
keeping it overnight at 0 C, a cream white precipitate was
formed, which was ﬁltered, washed with ethanol and dried in
vacuo over P4O10 and recrystallized from methanol.
Yield: 75%; mp > 300 C; IR (KBr) cm1: 3443 (O–H),
3196 (N–H), 3010 (C–H), 1617 (C‚O), 1411 (C–N), 1066,
885, 771; 1H NMR (300 MHz, d ppm from TMS in DMSO-
d6, 300 k): d 11.67–12.56 (4H, Br N–H), d 4.20–4.35 (s, 4H,
C–H), d 2.94–3.02 (s, 8H, C–H2);
13C NMR (CDCl3) (d,
ppm): 173.5 (C‚O), 38.09 (4CH2); ESI MS (m/z) 348 [M]
+,
349 [M+1]+; Elem. Anal. Calcd. C 41.39%, H 5.70%, O
36.76%, N 16.09%; found C 41.40%, H 5.72%, O 36.78%,
N 16.10%.
2.1.2. Synthesis of cobalt(II) complex
Solution of CoCl2Æ6H2O (0.711 g, 3 mmol) dissolved in 20 ml
methanol was added dropwise to a methanolic solution
(20 ml) of the ligand (1.044 g, 3 mmol) with continuous stir-
ring. The resulting solution was stirred for 7 h at 30 C and
the solution was reduced to half of its volume. It was then
allowed to stand overnight in a refrigerator. A light pink prod-
uct separates out, which was isolated by ﬁltration under vac-
uum. It was washed thoroughly with hexane and dried in
vacuo over fused CaCl2. The compound was recovered in solid
state. It was recrystallized from methanol.
Yield: 65%; mp > 300 C; UV–Vis (DMSO) cm1: 12,748–
13,320, 16,885–17,487, 24,722–25,350; IR (KBr) cm1: 3443
(O–H), 3194 (N–H), 2977 (C–H), 1606 (C‚O), 1369 (C–N),
1085, 881, 637, Far IR (CsI, cm1) 452 (Co–N), 345 (Co–
Synthesis, characterization and biological screening S745Cl). 1H NMR (300 MHz, d ppm from TMS in DMSO-d6, 300
k): d 11.70–12.60 (4H, Br, N–H), d 4.22–4.40 (4H, C–H), d
2.97–3.08 (8H, C–H2),
13C NMR (CDCl3) (d, ppm) 171.2
(C‚O), 46.00 (4CH2). ESI MS (m/z) 478 [M]
+, 480
[M+2]+. Molar conductance, Km (X
1cm2 mol1, 103
DMSO, r.t.): 32. leff (r.t., BM): 4.98. Elem. Anal. Calcd. C
30.15%, H 4.10%, O 26.77%, N 11.72%; found C 30.17%,
H 4.11%, O 26.78%, N 11.75%.
2.1.3. Synthesis of nickel(II) complex
This compound was also synthesized by the above same proce-
dure except that NiCl2Æ6H2O was used instead of CoCl2Æ6H2O.
A light green product was obtained which was recrystallized
from methanol.
Yield 62%; mp > 300 C; UV–Vis (DMSO) cm1: 11,668,
13,351, 14,662, 19,120, 24,390; IR (KBr) cm1: 3417(O–H),
3190 (N–H), 2978 (C–H), 1602 (C‚O), 1386 (C–N), 1063,
811, 614, Far IR (CsI, cm1) 468 (Ni–N), 340 (Ni–Cl). 1H
NMR (300 MHz, d ppm from TMS in DMSO-d6, 300 k): d
11.71–12.60 (4H, Br, N–H), d 4.25–4.37 (4H, C–H), d 2.96–
3.10 (8H, C–H2).
13C NMR (CDCl3) (d, ppm) 176.5 (C‚O),
49.50 (4CH2). ESI MS (m/z) 479 [M]
+, 481 [M+2]+. Molar
conductance, Km (X
1cm1 mol1, 103 DMSO, r.t.): 34. leff
(r.t., BM): 2.97. Elem. Anal Calcd. C 30.16%, H 4.10%, O
26.79%, N 11.72%; found C 30.17%, H 4.12%, O 26.80%,
N 11.73%.
2.1.4. Synthesis of copper(II) complex
This compound was also synthesized by the above same proce-
dure except that CuCl2Æ2H2O was used instead of CoCl2Æ6H2O.
A Sky blue product was obtained, which was recrystallized
from methanol.
Yield: 67%; mp > 300 C; UV–Vis (DMSO) cm1: 13,824–
14,392, 18,892–19,365, 24,870–25,435; IR (KBr) cm1: 3419
(O–H), 3189 (N–H), 2976 (C–H), 1600 (C‚O), 1390 (C–N),
1075, 888, 644, Far IR (CsI) cm1: 431 (Cu–N), 335 (Cu–
Cl). 1H NMR (300 MHz, d ppm from TMS in DMSO-d6,
300 k): d 11.72–12.61 (4H, N–H), d 4.23–4.39 (4H, C–H), d
2.97–3.11 (8H, C–H2);
13C NMR (CDCl3) (d, ppm): 174.9
(C‚O), 44.80 (4CH2). ESI MS (m/z) 483 M
+, 485 [M+2]+.
Molar conductance, Km (X
1cm1 mol1, 103 DMSO, r.t.):
29. leff (r.t., BM): 1.98; Elem. Anal. Calcd. C 29.86%, H
4.10%, O 26.52%, N 11.60%; found C 29.88%, H 4.12%, O
26.55%, N 11.63%.
2.2. Biological activity
2.2.1. In vitro antifungal activity
2.2.1.1. Growth conditions and media. Candida albicans ATCC
10261, Candida tropicalis ATCC 750 and Candida glabrata
ATCC 90030 used in this study were obtained from the Indian
Institute of Integrative Medicine, Jammu, India. Stock cul-
tures were maintained on slants of nutrient agar (yeast extract
1%, peptone 2%, D-glucose 2% and agar 2.5%) (HiMedia) at
4 C. To initiate growth for experimental purposes, one loop
full of cells from an agar culture was inoculated into 30 ml
of YEPD (yeast extract, peptone, glucose) nutrient medium
and incubated at 37 C for 24 h, i.e. up to stationary phase
(primary culture). The cells from primary culture
(108 cells ml1) were re-inoculated into 100 ml fresh YEPD
(yeast extract, peptone, glucose) medium and grown for 8–10 h, i.e., up to mid-log phase (106 cells ml1). Microbial cul-
tures, freshly grown at 37 C were appropriately diluted in
sterile YEPD broth to obtain the cell suspension at
106 CFU ml1. All inorganic chemicals were of analytical
grade and were procured from E. Merck (India).
2.2.1.2. Minimum inhibitory concentration. Theminimum inhib-
itory concentration (MIC) was deﬁned as the lowest concentra-
tion of test compounds that causes decrease in absorbance
compared with that of the control (no test compound). MIC
was determined in vitro in triplicate by broth dilution method
(NCCLS, 2002) and average of them was considered. Synchro-
nized yeast phase C. albicans, C. tropicalis and C. glabrata cells
were used in all experiments.2.2.1.3. Sterol composition assay. A singleCandida colony from
an overnight Sabouraud Dextrose Agar (Difco) plate culture
was used to inoculate 50 ml of Sabouraud Dextrose Broth (Dif-
co) for control and for various concentrations of test com-
pounds. The cultures were incubated for 16 h and harvested by
centrifugation at 2700 rpm for 5 min. The net weight of the cell
pellet was determined. Three milliliters of 25% alcoholic potas-
sium hydroxide solution was added to each pellet and vortex
mixed for 1 min. Cell suspensions were transferred to sterile
borosilicate glass screw-cap tubes and were incubated in 85 C
water bath for 1 h. Following incubation, tubes were allowed
to cool. Sterols were then extracted by the addition of a mixture
of 1 ml of sterile distilled water and 3 ml of n-heptane followed
by vigorous vortex mixing for 3 min. The heptane layer was
transferred to a clean borosilicate glass screw-cap tube and
stored at 20 C. Prior to analysis, a 20-ll aliquot of the sterol
extract was diluted ﬁvefold in 100% ethanol and scanned spec-
trophotometrically between 240 and 300 nmwith a Spectropho-
tometer (Systronics UV–Visible Spectrophotometer 117).
Ergosterol content is calculated as a percentage of thewetweight
of the cell as described by Breivik and Owades (1957).2.2.2. MTT assay
H9c2 rat cardiac myoblasts were cultured and maintained as
monolayer in Dulbecco’s modiﬁed Eagle’s medium (DMEM),
high glucose, supplemented with 10% fetal bovine serum (heat
inactivated), 100 units/ml penicillin, 100 lg/ml streptomycin,
and 2.5 lg/ml amphotericin B, at 37 C in humidiﬁed incuba-
tor with 5% CO2 (Gupta et al., 2006). Only viable cells were
used in the assay. Exponentially growing cells were plated at
1.2 · 104 cells per well into 96-well plates and incubated for
48 h before the addition of drugs to achieve the maximum con-
ﬂuency of the cells. Stock solutions were prepared by dissolv-
ing the compounds in 20% (v/v) DMSO and further diluted
with fresh complete medium to achieve 1 M concentration.
Cells were incubated with different concentrations of the stan-
dard drug SD and compounds KNi, KCu and ligand (K) for
48 h at 37 C in 5% CO2 humidiﬁed incubator together with
untreated control sample. At appropriate time points, cells
were washed in PBS, treated with 50 ll MTT solution (5 mg/
ml, tetrazolium salt) and incubated for 45 min at 37 C. After
45 min of incubation at 37 C, the cell supernatants were dis-
carded, MTT crystals were dissolved with acid isopropanol
and the absorbance measured at 570 nm. All assays were per-
formed in triplicate. Percent viability was deﬁned as the rela-
S746 R.A. Sheikh et al.tive absorbance of treated versus untreated control cells. Plates
were analyzed in an ELISA plate reader (Labsystems Multis-
kan RC, Helsinki, Finland) at 570 nm with a reference wave-
length of 655 nm.3. Results and discussion
Some macrocyclic tetradentate nitrogen donor (N4) ligand
6,7,14,15-tetrahydroxy-1,4,9,12-tetraazacyclohexadecane-5,8,13,
16-tetrone based transition metal complexes of the type
[M(C12H20O8N4)Cl2] where M= Cu(II), Ni(II) and Co(II) were
isolated in satisfactory yields. The structure of the ligand and its
metal complexes were established using various spectroscopic
studies. The analytical data of these compounds are in good
agreementwith their composition. The compoundsdonot under-
go any weight loss up to 255 C, 245 C, 250 C, respectively,
which suggest their fair thermal stability. The structureof all com-
plexes was established by comparing spectral data (IR, UV–Vis
and 1H NMR) with their respective ligands and was further sup-
ported by their ESI MS and thermo gravimetric analysis.
3.1. Electronic spectra
3.1.1. Cobalt(II) complex
The electronic spectrum of the mononuclear cobalt(II) complex
exhibits absorption bands in the range 12,748–13,320, 16,885–
17,487 and 24,722–25,350 cm1, which may be assigned to
4T1g(F)ﬁ 4T2g(F)(m1), 4T1gﬁ 4A2g(m2) and 4T1g(F)ﬁ
4T1g(P)(m3) transitions, respectively, suggesting an octahedral
geometry around a Cobalt(II) ion, in the complexes under
study. Furthermore, the magnetic moment measurements re-
corded at room temperature lie at 4.98 BM. This value is indic-
ative of an octahedral geometry (Carlin, 1965; Chandra and
Gupta, 2004) of these complexes.
3.1.2. Copper(II) complex
The electronic spectrum of the mononuclear copper(II) com-
plex recorded at room temperature, in DMF solution, shows
broad band absorption in the range 13,824–14,392, 18,892–
19,365 and 24,890–25,435 cm1, which may be assigned to
2B1gﬁ 2A1g, (dx2  y2 ﬁ dz2 )(m1), 2B1gﬁ 2B2g, (dx2  y2 ﬁ
dzy)(m2), and
2B1gﬁ 2Eg, (dx2  y2 ﬁ dzy, dyz)(m3) transition
and it is in conformity with octahedral geometry, an indication
of the most probable geometric conﬁguration of the synthe-
sized metal complexes is their magnetic moment values. So,
it has been further conﬁrmed by the magnetic moment mea-
surements, room temperature values lie at 1.98 BM. corre-
sponding to the presence of one unpaired electron and it
supports an octahedral geometry (Chandra, 2009).
3.1.3. Nickel(II) complex
The magnetic moment of the Ni(II) complex at room temper-
ature lies at 2.97 BM. These values are in tune with high spin
conﬁguration and show the presence of an octahedral environ-
ment around the Ni(II) ion. The electronic spectra of the nick-
el(II) complex showed transition bands at 11,668, and 13,351,
14,662 cm1 which are assigned to the transition 3A2gﬁ3T2g,
19,120(shoulder), 24,390 cm1 which are assigned to the tran-
sition 3A2gﬁ3T1g(F). These bands indicate an octahedral
geometry around the nickel(II) ion in its complex.3.2. IR spectra
3.2.1. Macrocyclic ligand
IR spectrum of the ligand does not exhibit any band corre-
sponding to the free primary amine group. The absence of a
broad absorption band in the region 3100–2500 cm1 charac-
teristic for (O–H) group of carboxylic acid and presence of
an absorption band in the region 1675–1775 cm1 characteris-
tic for the carbonyl group (C‚O) in tartaric acid, indicates
that the OH group of tartaric acid was detached from the
COOH group to form a bond between carboxyl carbon atom
and amino group nitrogen of ethylenediamine, also suggesting
complete condensation of the reactants and the elimination of
water molecule. This has been conﬁrmed by the appearance of
a strong signal at 1411 cm1 which may be attributed to the C–
N bond. A sharp medium intensity band observed at 3196 cm
1 may be assigned to t(N–H) of the secondary amine group.
The ligand also shows a signal for the C‚O at 1617 cm1 and
C–H at 3010 cm1 vibrations. The low frequency of C‚O
group as compared to acetone (1715 cm1) is attributed to res-
onance with lone pair of the nitrogen.
3.2.2. Complexes
The molar conductance measurements of the complexes in
DMF correspond to nonelectrolytic nature. Thus, the com-
plexes may be formulated as [M(K)Cl2] where M= Ni(II),
Co(II), and Cu(II) and K is [(C12H20O8N4)]. The shifting in
the band of t(C–N) toward the lower wave number in the me-
tal complexes indicates that the coordination takes place
through the nitrogen of the t(C–N) group, hence implying that
the ligand (K) is tetradentate. This indicates the ﬂow of elec-
tron density toward the metal atom through the C–N group.
This has been ﬁnally established through far IR spectra by
the appearance of new signals seen at 482, 470, 452 cm1 in
the spectra of metal complexes which gives us clear proof for
the presence of metal–nitrogen bond in Co(II), Ni(II), and
Cu(II) complexes, respectively. Other vibrating signals seen
at 347, 337 and 330 cm1 in the spectra of metal complexes
give us proof of the presence of metal–chlorine bond in Co(II),
Ni(II) and Cu(II) complex, respectively.
3.3. 1H NMR spectra
The 1H NMR spectrum of the ligand shows a broad signal in
the range 11.67–12.56 ppm which is attributed to amide CO–
N–H, (4H) and does not show any signal corresponding to
the primary amine. A signal appearing in the range 4.20–
4.35 ppm has been ascribed to methylene protons OC–N–
CH2, (8H), whereas C–H (4H) protons appear in the range
2.94–3.02 ppm. The NMR spectrum of the ligand is consistent
with the single species present in the solution, since only one
set of signals is observed in the ligand. These proton signals
undergo down ﬁeld shifting in all the metal complexes of the
ligand, because of the paramagnetic effect of metal(II) ions
and hence support the coordination of the ligand toward the
metal ions and also the macrocyclic nature of the product.
3.4. Electro spray ionization mass spectra (ESI MS)
The electro spray ionization mass spectra (ESI MS) of the li-
gand and the complexes were studied in DMSO solution. A
Synthesis, characterization and biological screening S747positive ion ESI mass spectrum of the ligand conﬁrms the pro-
posed formula by showing a peak at m/z 349 corresponding to
the moiety (C12H20O8N4) atomic mass m/z 348.14. The series
of peaks in the range m/z 63.5, 102.9, 134.9, 192.9, 244.7,
306.1, etc., may be assigned to various fragments. These data
suggest 2+2 condensation of tartaric acid and ethylenedia-
mine. Their intensity gives an idea of the stability of fragments.
Similarly positive ion ESI MS of cobalt and copper, negative
ion ESI MS nickel complexes shows a peak at m/z 478, 483,
479, respectively, which is consistent with the molecular ion
fragment and it supports the proposed structure of the com-
plexes. [M+2]+ fragments were observed in all the metal com-Figure 1 TG/DTA spectrum
Figure 2 TG/DTA spectrplexes. This may be possible due to presence of isotopic
chlorine in low quantities. In some cases, the molecular ion
peak was also associated with the solvent, water molecules
and some adduct ions from the mobile phase solution
(Yamashita and Fenn, 1984; Mann, 1990).
3.5. Thermo gravimetric analysis (TG/DTA)
3.5.1. Macrocyclic ligand
The thermal analysis (TG/DTA) of the ligand and its metal
complexes was recorded under nitrogen atmosphere at the
heating rate of 10 C/min. The ligand is stable up to 215 Cof macrocyclic ligand (K).
um of Co(II) complex.
Table 1 Minimum inhibitory concentrations (MIC) of bioactive compounds tested against different Candida spp.
Bioactive compound MIC (lg/ml)
Candida albicans ATCC 44829 Candida tropicalis ATCC 750 Candida glabrata ATCC 90030
[Ni(K)Cl2] 80 90 100
[Cu(K)Cl2] 90 110 120
[Co(K)Cl2] 140 150 170
Ligand [K] 190 300 300
S748 R.A. Sheikh et al.and shows a continuous weight loss up to 380 C, Therefore
the whole ligand gets decomposed in a single step (Fig 1).
The DTA of the ligand shows two endothermic peaks; one
broad endothermic peak at 228 C with a shoulder at
210 C, which correspond to the melting and the ﬁrst inﬂexion
point. The second inﬂexion on the DTA curve occurs at
351 C which represents a small weight loss step from
360 C to 380 C.
3.5.2. Complexes
The thermal gravimetric (TG) analysis was used as a probe to
prove the associated water or solvent molecules to be in coor-
dination sphere or in crystalline form (Emara and Omima,
2007). The thermo gram of copper(II), nickel(II) and cobalt(II)
complexes are more stable than the macrocyclic ligand and
does not decompose up to 255 C, 253 C and 250 C, respec-
tively (Fig. 2). It shows a major step of decomposition from
255 C to 330 C which is detected by DTA at 320 C, this cor-
responds to the loss of two phthalic acids and two ethylenedi-
amine moieties (observed weight 75.5%, theoretical weight
72.85%). It is very interesting to note that the complexes gain
some 7% weight from 335 C to 410 C and do not decompose
further. This weight gain of complexes may be attributed to the
migration of the metal (Mlayer) to the new vacant sites pro-Table 2 % Ergosterol decrease of control cells and treated samples
experiments.
Candida albicans ATCC 10261 Candida tropicalis AT
Sample % Decrease Sample
[Ni(K)Cl2]
Control 0 Control
20 lg/ml 22 30 lg/ml
40 lg/ml 48 60 lg/ml
80 lg/ml 79 90 lg/ml
[Cu(K)Cl2]
Control 0 Control
30 lg/ml 18 30 lg/ml
60 lg/ml 32 60 lg/ml
90 lg/ml 67 110 lg/ml
[Co(K)Cl2]
Control 0 Control
50 lg/ml 15 50 lg/ml
100 lg/ml 28 100 lg/ml
140 lg/ml 51 150 lg/ml
Ligand [K]
Control 0 Control
50 lg/ml 12 50 lg/ml
100 lg/ml 21 100 lg/ml
190 lg/ml 41 300 lg/mlduced by the partial reduction of M2+ to M1+ in case of Cop-
per and M4+ to M2+ in case of cobalt and nickel, then
subsequent oxidation of M1+, M2+ in copper, cobalt and
nickel complexes, respectively (Gaillot et al., 2005; Cheney
et al., 2008).
3.6. Anticandidial activity
3.6.1. Minimum inhibitory concentration (MIC)
Table 1 summarizes the in vitro susceptibilities of three
Candida species. The data are reported as MICs required to in-
hibit the growth of the tested species. All the Candida species
were found to be more sensitive to Ni(II) and Cu(II) com-
plexes, compared to Co(II) complex and the ligand.
3.6.2. Sterol assay
Sterol quantitation method is employed to determine ergos-
terol content of fungal cell membrane. An important mecha-
nism of action by which antifungal drugs inhibit yeast cell
growth is through disruption of the normal sterol biosyn-
thetic pathway, leading to a reduction in ergosterol biosyn-
thesis (Kelly et al., 1995). Ergosterol is the major sterol
component of the yeast cell membrane and is responsible
for maintaining cell integrity and function (Bard et al.,in different Candida species. The data represents mean of three
CC 750 Candida glabrata ATCC 90030
% Decrease Sample % Decrease
0 Control 0
20 30 lg/ml 18
39 60 lg/ml 35
70 100 lg/ml 68
0 Control 0
16 40 lg/ml 16
32 80 lg/ml 30
62 120 lg/ml 60
0 Control 0
13 50 lg/ml 13
25 100 lg/ml 24
47 170 lg/ml 45
0 Control 0
10 50 lg/ml 09
19 100 lg/ml 16
39 300 lg/ml 28
Figure 3 UV spectrophotometric sterol proﬁle of Candida albicans. (A) In presence of Ni(II) complex in concentration range of 20–
40 lg/ml. (B) Cu(II) complex in concentration range of 30–90 lg/ml. (C) Co(II) complex in concentration range of 50–140 lg/ml. (D)
Ligand in concentration range of 50–190 lg/ml. (Data represents mean of three experiments).
Figure 4 Percentage of viable cells after 48 h pre-treatment of H9c2 myoblasts with SD, ligand (K), KNi and KCu evaluated by MTT
assay.
Synthesis, characterization and biological screening S7491978; Rodriguez et al., 1985). Therefore, disruption of this
pathway by drugs or additional compounds leads to fungista-
sis. Total sterol content of samples treated with varying con-
centrations of Ni(II) complex, Co(II) complex, Cu(II)
complex and ligand was studied (Table 2). From the results,
it is clear that with increase in test compound concentrations,
% ergosterol inhibition increased and ﬁnally at MIC values, aﬂat line was observed indicating absence of ergosterol in the
sample. Fig. 3(A, B, C, D) shows typical scans of % ergos-
terol inhibition in C. albicans ATCC 10261 in the presence
of different test compound concentrations. It was observed
that Ni(II) complex and Co(II) complex drastically reduces
ergosterol content of cell membrane followed by the Cu(II)
complex and the ligand itself.
Scheme 1 (a) Synthesis of ligand and (b) its metal complexes [Cu(II), Co(II), and Ni(II)].
S750 R.A. Sheikh et al.3.7. Toxicity proﬁle
To ensure the toxicity of the active compounds (KNi and
KCu) and the ligand (K) they were tested against H9c2 cardiac
myoblasts. A subconﬂuent population of H9c2 cells was trea-
ted with increasing concentrations of these compounds and the
number of viable cells was measured after 48 h by MTT cell
viability assay. The concentration range of all the compounds
was 3.13–200 lM. Fig. 4 depicts that all the compounds
including the reference drug (Fluconazole) showed a viability
of 100% at the concentration range of 3.13 lM. At the concen-
tration of 6.25 lM ligand (K), compound KNi and the refer-
ence drug showed 100% viability whereas compounds KCu
showed 98% viability. At the concentration of 12.5 lM, ligand
(K), compound KNi, and reference drug again showed 100%
viability while compound KCu showed 94% viability. At the
concentration of 25 lM reference drug, ligand (K), compound
KNi, and compound KCu offered a remarkable viability of
98%, 96%, 94% and 87%, respectively. The range of viability,
however, got sharply decreased at the concentration of
200 lM. The results indicated that the ligand (K) and the com-
pound (KNi) showed remarkable viability of 94% and 96%,
respectively at a concentration of 25 lM. The mean percentage
viability sharply decreased with increase in concentration
above 50 lM (see Fig. 4; Scheme 1).4. Conclusion
This research work has achieved the synthesis of a new series
of macrocyclic tetradentate nitrogen donor (N4) ligand
6,7,14,15-tetrahydroxy-1,4,9,12-tetraazacyclohexadecane-5,8,
13,16-tetrone based transition metal complexes of the type
[M(C12H20O8N4)Cl2] where M= Cu(II), Co(II) and Ni(II)
and screened them for their anticandidal property by perform-
ing minimum inhibitory concentration (MIC) along withergosterol composition assay against the tested Candida spe-
cies. Antimicrobial results showed that metal complexes have
high killing activity compared to the ligand. MIC values de-
creased almost stoichiometrically with multiplication of struc-
ture. A whole line of current antifungals target ergosterol
biosynthesis pathway or its end product which is unique to
fungi. At respective MIC values Ni(II) complex leads to
enormous reduction in ergosterol content followed by Cu(II)
complex, Co(II) complex and the ligand, respectively. Toxicity
studies performed on H9c2 cardiac myoblasts showed that the
compound KNi and the ligand (K) showed viability of 96%
and 94%, respectively, at a concentration of 25 lM.Acknowledgment
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